TEL
79
4
HD
43
-4
RSG
70
2
NRG
75
-10
IPG
54
2
ADM
44
5
GD
69
2
NDAQ
49
-3
VMC
68
2
SWN
55
2
LLY
70
2
DUK
50
3
SPG
68
4
CA
44
4
DIS
54
-14
GOOG
93
2
HCP
78
2
AON
26
3
INTU
74
4
MSI
57
2
TEL
79
4
HD
43
-4
RSG
70
2
NRG
75
-10
IPG
54
2
ADM
44
5
GD
69
2
NDAQ
49
-3
VMC
68
2
SWN
55
2
LLY
70
2
DUK
50
3
SPG
68
4
CA
44
4
DIS
54
-14
GOOG
93
2
HCP
78
2
AON
26
3
INTU
74
4
MSI
57
2
Financhill
Back

Achieve Life Sciences 10K Form

Buy
52

ACHV
Achieve Life Sciences

Last Price:
4.71
Seasonality Move:
5.03%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ACHV News And Ratings

See the #1 stock for the next 7 days that we like better than ACHV

ACHV Financial Statistics

Sales & Book Value

Annual Sales: $5.06M
Cash Flow: $-4.37M
Price / Cash Flow: 0
Annual Sales: $-0.07
Price / Book: 0

Profitability

EPS (TTM): -1.51000
Net Income (TTM): $-29.82M
Gross Margin: $29.88M
Return on Equity: 0%
Return on Assets: 0%

Achieve Life Sciences Earnings Forecast

Key Achieve Life Sciences Financial Ratios

  • The Gross Profit Margin over the past 17 years for ACHV is 100.00%.
  • The Selling, General & Administrative Expenses for ACHV have been equal to 28.26% of Gross Profit Margin.
  • The Interest Expense is -9.57% of Operating Income.
  • Per Share Earnings over the last 30 years have been positive in 20 years.

Achieve Life Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ACHV
CUSIP: 004468
Website: achievelifesciences.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ACHV Technical Analysis vs Fundamental Analysis

Buy
52
Achieve Life Sciences (ACHV) is a Buy

Is Achieve Life Sciences a Buy or a Sell?